Literature DB >> 4110107

Reduction and reoxidation of Australia antigen: loss and reconstitution of particle structure and antigenicity.

N Sukeno, R Shirachi, J Yamaguchi, N Ishida.   

Abstract

Reduction of Australia antigen with dithiothreitol resulted in the loss of antigenicity and morphological integrity. Oxidation of the reduced Australia antigen reconstituted both of these characters.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4110107      PMCID： PMC356275     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  8 in total

1.  DITHIOTHREITOL, A NEW PROTECTIVE REAGENT FOR SH GROUPS.

Authors:  W W CLELAND
Journal:  Biochemistry       Date:  1964-04       Impact factor: 3.162

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Australia antigen: large-scale purification from human serum and biochemical studies of its proteins.

Authors:  J L Gerin; P V Holland; R H Purcell
Journal:  J Virol       Date:  1971-05       Impact factor: 5.103

4.  Biophysical properties of Australia antigen.

Authors:  J L Gerin; R H Purcell; M D Hoggan; P V Holland; R M Chanock
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

5.  Some antigenic and physical properties of virus-like particles in sera of hepatitis patients.

Authors:  L F Barker; K O Smith; W D Gehle; N R Shulman
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

6.  Serum hepatitis antigen (SH): rapid detection by high voltage immunoelectroosmophoresis.

Authors:  A M Prince; K Burke
Journal:  Science       Date:  1970-08-07       Impact factor: 47.728

7.  Rapid detection of Australia antigen by counterimmunoelectrophoresis.

Authors:  D J Gocke; C Howe
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

8.  Australia antigen (a hepatitis-associated antigen): purification and physical properties.

Authors:  I Millman; L A Loeb; M E Bayer; B S Blumberg
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307
  8 in total
  10 in total

1.  Conformational studies of Australia antigen by optical rotatory dispersion and circular dichroism.

Authors:  N Sukeno; R Shirachi; H Shiraishi; N Ishida
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

2.  Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptide.

Authors:  R C Kennedy; G R Dreesman; J T Sparrow; A R Culwell; Y Sanchez; I Ionescu-Matiu; F B Hollinger; J L Melnick
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

3.  Orcein staining of hepatitis B antigen in paraffin sections of liver biopsies.

Authors:  K P Deodhar; E Tapp; P J Scheuer
Journal:  J Clin Pathol       Date:  1975-01       Impact factor: 3.411

4.  Demonstration of hepatitis B surface antigen by orcein staining in paraffin sections of cirrhotic liver.

Authors:  I Bartók; E Remenár; J Tóth
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-02-16

Review 5.  The hepatitis B virus and its DNA polymerase: the prototype three-D virus.

Authors:  S Z Hirschman
Journal:  Mol Cell Biochem       Date:  1979-07-15       Impact factor: 3.396

6.  Biophysical and biochemical heterogeneity of purified hepatitis B antigen.

Authors:  G R Dreesman; F B Hollinger; J R Suriano; R S Fujioka; J P Brunschwig; J L Melnick
Journal:  J Virol       Date:  1972-09       Impact factor: 5.103

7.  Multiple chemical forms of hepatitis B surface antigen produced in yeast.

Authors:  D E Wampler; E D Lehman; J Boger; W J McAleer; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  Allelic subtypic determinants of hepatitis B surface antigen (i and t) that are distinct from d/y or w/r.

Authors:  H Ohnuma; A Machida; H Okamoto; F Tsuda; M Sakamoto; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

9.  Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment.

Authors:  A P Huovila; A M Eder; S D Fuller
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

Review 10.  Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Authors:  Joan Kha-Tu Ho; Beena Jeevan-Raj; Hans-Jürgen Netter
Journal:  Viruses       Date:  2020-01-21       Impact factor: 5.048
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.